Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 1, 2003, Pages 266-271

  Wang, Cheng ^a   McInnis, Justin ^a   West, J Brett ^a   Bao, Jinfeng ^a   Anastasio, Noelle ^a   Guidry, Jon A ^a   Ye, Yanping ^a   Salvemini, Daniela ^b   Johnson, Kenneth M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b MetaPhore Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; M 40404; MANGANESE DERIVATIVE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); N METHYL DEXTRO ASPARTIC ACID; PHENCYCLIDINE; PROTEIN BAX; PROTEIN BCL X; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION;

ACOUSTIC STIMULATION; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CEREBRAL CORTEX; DNA FRAGMENTATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FREE RADICAL SCAVENGERS; IN SITU NICK-END LABELING; MOLECULAR MIMICRY; NEUROTOXICITY SYNDROMES; ORGANOMETALLIC COMPOUNDS; PHENCYCLIDINE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; SUPEROXIDE DISMUTASE;

EID: 0037215606     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.041798     Document Type: Article

References (47)

1. 2A receptor antagonists and potential antipsychotic drug, facilitates N-methyl-D-aspartate-mediated neurotransmission in the rat prefrontal cortical neurons in vitro. Neuropsychopharmacology 18:197-209.
2. Bakshi VP and Geyer MA (1995) Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology 122:198-201.
3. Bakshi VP, Swerdlow NR, and Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating deficits of the startle response. J Pharmacol Exp Ther 271:787-794.
4. Benes FM (1995) Altered glutamatergic and GABAergic mechanism in the cingulate cortex of the schizophrenic brain. Arch Gen Psychiatry 52:1015-1018.
5. Benes FM, Mc Sparren J, Bird ED, and Vincent SL (1991) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48:996-1001.
6. Braff DL, Grillon C, and Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215.
7. Carlin AS, Grant I, Adams KM, and Reed R (1979) Is phencyclidine (PCP) abuse associated with organic mental impairment?Am J Drug Alcohol Abuse 6:273-281.
8. Chao DT and Korsmeyer SJ (1998) Bcl-2 family: Regulators of cell death. Annu Rev Immunol 16:395-419.
9. Cosgrove J and Newell TG (1991) Recovery of neuropsychological functions during reduction in use of phencyclidine. J Clin Psychol 47:159-169.
10. Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS, and Slack RS (1999) Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J Neurosci 19:7860-7869.
11. Gavriele Y, Sherman Y, and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
12. Goldman-Rakic PS (1999) The physiological approach: Functional architecture of working memory and disordered cognition in schizophrenia. Biol Psychiatry 46:650-661.
13. Goldman-Rakic PS and Selemon LD (1997) Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 23:437-457.
14. Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris H, Lee H, Tourville J, Caviness VS Jr, Faraone SV, and Tsuang MT (1999) Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 56:537-547.
15. Grilli M, Pizzi M, Memo M, and Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science (Wash DC) 274:1383-1385.
16. Hanania T, Hillman GR, and Johnson KM (1999) Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit. Synapse 31:229-239.
17. Hertzmann M, Reba RC, and Kotylarov EV (1990) Single photon emission computerized tomography in phencyclidine and related drug abuse. Am J Psychiatry 147:255-256.
18. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, and Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science (Wash DC) 283:70-74.
19. Javitt DC and Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
20. Jentsch JD, Redmond DE Jr, Elsworth JD, Taylor JR, Youngren KD, and Roth RH (1997) Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term phencyclidine administration. Science (Wash DC) 277:953-955.
21. Johnson KM, Phillips M, Wang C, and Kevetter GA (1998) Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex. J Neurosci Res 52:709-722.
22. Karper LP, Grillon C, Morisey K, Charney DS, and Krystal JH (1994) The effect of ketamine on the acoustic startle response. Soc Neurosci Abstr 20:482.
23. Keith VA, Mansbach R, and Geyer MA (1991) Failure of haloperidol to block the effects of phencyclidine and dizolcipine on prepulse inhibition of startle. Biol Psychiatry 30:557-566.
24. Lahti AC, Holcomb HH, Laporte D, and Tamminga CA (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6:869-872.
25. Lewis DA (1997) Development of the prefrontal cortex during adolescence: Insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16:385-398.
26. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, and Kelley R (1959) Study of a new psychotropic drug-sernyl. Arch Neural Psychiatry 81:363-369.
27. Mansbach RS and Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299-308.
28. McInnis J, Wang C, Anastasio N, Hultman M, Ye YP, Salvemini D, and Johnson KM (2002) The role of superoxide and nuclear factor-κB signaling in N-methyl-D-aspartate-induced necrosis and apoptosis. J Pharmacol Exp Ther 301:478-487.
29. Moghaddam B, Adams B, Verma A, and Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
30. Mohn AR, Gainetdinov RR, Caron MG, and Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
31. Murray RM, O'Callaghan E, Castle DJ, and Lewis SW (1992) A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 18:319-332.
32. Olney JW and Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007.
33. Olney JW, Labruyere J, and Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (Wash DC) 244:1360-1362.
34. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, and Sesma MA (1991) NMDA antagonist neurotoxicity: Mechanism and prevention. Science (Wash DC) 254:1515-1518.
35. Pearlson GD and Marsh L (1999) Structural brain imaging in schizophrenia: A selective review. Biol Psychiatry 46:627-649.
36. Pietraszek M and Ossowska K (1998) Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats. Naunyn-Scmmeideberg's Arch Pharmacol 357:466-471.
37. Pilowski LS, Kerwin RW, and Murray RM (1993) Schizophrenia: A neuro-developmental perspective. Neuropsychopharmacology 9:83-91.
38. Rabacchi SA, Bonfanti L, Liu LL, and Maffei L (1994) Apoptotic cell death induced by optic nerve lesion in the neonatal rat. J Neurosci 14:5292-5301.
39. Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorsdi JA, and Riley DP (1999) A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science (Wash DC) 286:209-210.
40. Uberti D, Yavin E, Gil S, Ayasola KR, Goldfinger N, and Rotter V (1999) Hydrogen peroxide induces nuclear translocation of p53 and apoptosis in cells of oligodendroglia origin. Mol Brain Res 65:167-175.
41. Wang C, Kaufmann JA, Sanchez-Ross MG, and Johnson KM (2000a) Mechanisms of N-methyl-D-aspartate-induced apoptosis in phencyclidine treated cultured forebrain neurons. J Pharmacol Exp Ther 294:287-295.
42. Wang RY, Liang X, Jardemark KE, and Arvanov V (2000b) Facilitation of NMDA transmission by olanzapine, in Olanzapine (Zyprexa®): A Novel Antipsychotic (Tran PV, Bymaster FP, Tye N, Herrera JM, Breir A, and Tollefson eds) pp 114-131, Lipnicott Williams & Wilkins Healthcare, Philadelphia.
43. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, and Johnson KM (2001) Long-term behavioral and nearodegenerative effects ofperinatal phencyclidine administration: Implications for schizophrenia. Neuroscience 107:535-550.
44. Wang C, Showalter VM, Hillman GR, and Johnson KM (1999) Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain. J Neurosci Res 55:762-769.
45. Weinberger DR (1987) Implications of normal development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669.
46. Weinberger DR, Berman KF, and Zec RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43:114-124.
47. Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Scwartzkroin PA, and Morrison RS (1998) Bax involvement in p53-mediated neuronal cell death. J Neurosci 18:1363-1373.